All Articles on COVID-19
Using advanced analytics to prevent adverse COVID-19 outcomesACT Center paper describes a novel predictive model that identifies patients at high risk of hospitalization or death at Kaiser Permanente Washington.
Scientists begin trial of combined COVID-19 and flu vaccineKPWHRI is recruiting Kaiser Permanente Washington members to take part.
COVID risks not meaningfully greater with estrogen-containing medicationsOral contraceptives, hormone therapy not linked to more severe COVID outcomes.
When is Paxlovid right for COVID-19 treatment?New risk model uses advanced analytics to guide informed treatment decisions at Kaiser Permanente Washington.
Top research highlights in 2022From cardiovascular health to cancer screening, these are the research stories that made headlines over the last year.
How did the pandemic impact hospital visits with animals?Top pediatric oncology hospitals reported lasting changes to programs involving visits with animals.
Updated results from COVID-19 vaccine booster trialIDCRC study finds rapid decline in vaccine-boosted neutralizing antibodies against Omicron variant BA.5
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.